IDH1 and glioma: Despite our enhanced understanding of the molecular pathogenesis of IDH-mutant glioma, however, effective treatments have yet to be developed and clinicians remain reliant on maximal safe surgical resection and various chemotherapeutic agents and radiation treatments to prolong survival (7).